Latest updates for Fda Guidance
Fresh curated links around FDA guidance are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- FDA Issues Draft Guidance Clarifying Use of Form FDA 3542
- FDA Regulations to Establish Minimum CGMP Requirements for Manufacturing, Packaging, Labeling, and Holding of Dietary Su
- FDA Issues Guidance on Protein Quality Testing for Infant Formula
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
FDA Regulations to Establish Minimum CGMP Requirements for Manufacturing, Packaging, Labeling, and Holding of Dietary Su...
On June 18, 2026, the Food and Drug Administration (“FDA”) announced the submission of a proposed collection of information to the Office of Management and Budget (“OMB”) pertainin...
FDA Issues Guidance on Protein Quality Testing for Infant Formula
The guidance was developed to help manufacturers and laboratories in the design, conduct, evaluation, and reporting of Protein Efficiency Ratio (PER) studies.
New guidance for infant manufacturers available
The FDA has issued final guidance for manufacturers of infant formula and laboratories conducting testing on infant formula. The guidance was developed to help manufacturers and la...
From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
TUESDAY, June 30, 2026 — The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year’s end. The FDA’s Human Food Program aims to pre...
FDA’s Human Foods Program Releases Updated 2026 Guidance Agenda
FDA Issues Final Guidance for Content of Human Factors Information in Medical Device Submissions
By Adrienne R. Lenz, Principal Medical Device Regulation Expert —
FDA Human Foods Program Updates 2026 Guidance Agenda to Include ‘Healthy’ Claim, Caffeine Labeling
The guidance agenda lists topics that the program is considering for possible guidance documents or revisions to existing guidance documents, spanning Food Chemical Safety, Dietary...
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of ex...
FDA Supports Grouping Several Phthalates for Cumulative Risk Assessment
FDA published a literature review on the eight phthalates currently approved for food contact uses to determine whether they should be considered chemically and/or pharmacologicall...
FDA warns four importers about safety verification failures
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until...
GRAS, additives, chemicals: Who should hold the authority?
-- OPINION --State leadership vs. a patchwork of regulations sums up of the controversy over the “FRESH Act” in a single phrase.Due to its controversial provisions on federal food...
<![CDATA[New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific...
FDA steps up import enforcement action on infant formula, cantaloupes and seafood
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.Re...
Following Infant Formula Incidents, FDA Urges Manufacturers to Implement Stronger, Substantive Supplier Oversight
The letter to industry was issued in response to the botulism outbreaks linked to Nara Organics and ByHeart formulas, which identified Clostridia in the whole milk powder ingredien...
FDA Calls On Infant Formula Industry to Safeguard Against Contaminants Introduced Through Supply Chains
FDA warns Florida supplement maker about sanitation and allergen risks
As part of its enforcement activities, the U.S. Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view u...
Codex Moves to Adopt Standardized Precautionary Allergen Labeling, Kicks UPFs Can Down the Road
During the 49th Meeting of the Codex Committee on Food Labeling (CCFL49), guidelines on risk-based precautionary allergen labeling, labeling for multipack foods, and emergency flex...
2026 Regulatory Agenda Released – Updates Information Regarding GRAS Rulemaking
At the Half: No Free Kicks in FDA’s 2026 Enforcement
As the World Cup has captured the attention of viewers around the globe, so has the Food and Drug Administration (FDA) when it comes to taking enforcement action against regulated...
The Battle over Flavor: FDA Wins This Round!
By Esther Petrikovsky & Andrew J. Hull —
FDA Releases Response Letter Denying Request to Set Temporary PFAS Tolerances
FDA cites three companies for failing to verify safety of a variety of imported products
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until...
FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.